Data as of Sep 22
| -0.71 / -1.80%|
The 5 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 45.00, with a high estimate of 52.00 and a low estimate of 41.00. The median estimate represents a +16.19% increase from the last price of 38.73.
The current consensus among 6 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.